IL6 and Alzheimer disease: A comparison of dynamic IL-6levels of acute AD patients undergoing surgical treatment between those with orwithout the use of ulinastatin revealed that the ulinastatin group showed astepwise reduction of IL-6 levels from the start of operation to 24 hours afteroperation (Figure 8C)[14].